Arcutis Biotherapeutics, Inc. (ARQT)
26.41
-0.76
(-2.80%)
USD |
NASDAQ |
Nov 20, 15:35
Arcutis Biotherapeutics 30-Day Average Daily Volume : 2.326M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 2.326M |
| November 18, 2026 | 2.368M |
| November 17, 2026 | 2.398M |
| November 16, 2026 | 2.440M |
| November 13, 2026 | 2.460M |
| November 12, 2026 | 2.491M |
| November 11, 2026 | 2.482M |
| November 10, 2026 | 2.479M |
| November 09, 2026 | 2.502M |
| November 06, 2026 | 2.512M |
| November 05, 2026 | 2.472M |
| November 04, 2026 | 2.291M |
| November 03, 2026 | 2.283M |
| November 02, 2026 | 2.324M |
| October 30, 2026 | 2.337M |
| October 29, 2026 | 2.912M |
| October 28, 2026 | 3.049M |
| October 27, 2026 | 3.165M |
| October 26, 2026 | 3.206M |
| October 23, 2026 | 3.222M |
| October 22, 2026 | 3.228M |
| October 21, 2026 | 3.218M |
| October 20, 2026 | 3.239M |
| October 19, 2026 | 3.241M |
| October 16, 2026 | 3.102M |
| Date | Value |
|---|---|
| October 15, 2026 | 3.080M |
| October 14, 2026 | 3.013M |
| October 13, 2026 | 2.995M |
| October 12, 2026 | 2.982M |
| October 09, 2026 | 2.982M |
| October 08, 2026 | 2.997M |
| October 07, 2026 | 2.974M |
| October 06, 2026 | 2.956M |
| October 05, 2026 | 2.908M |
| October 02, 2026 | 2.903M |
| October 01, 2026 | 2.953M |
| September 30, 2026 | 2.933M |
| September 29, 2026 | 2.919M |
| September 28, 2026 | 2.878M |
| September 25, 2026 | 2.813M |
| September 24, 2026 | 2.798M |
| September 23, 2026 | 2.765M |
| September 22, 2026 | 2.716M |
| September 21, 2026 | 2.691M |
| September 18, 2026 | 2.709M |
| September 17, 2026 | 2.180M |
| September 16, 2026 | 2.066M |
| September 15, 2026 | 1.959M |
| September 14, 2026 | 1.896M |
| September 11, 2026 | 1.880M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.367M |
| ADMA Biologics, Inc. | 3.747M |
| Alnylam Pharmaceuticals, Inc. | 2.712M |
| Anika Therapeutics, Inc. | 118570.5 |
| Savara, Inc. | 3.222M |